Endo International PLC

Find more results for SUSAN M. HUTSON´┐Ż

Officers and directors

Roger H. Kimmel
Independent Chairman of the Board
Rajiv De Silva
President, Chief Executive Officer, Director
Suketu P Upadhyay
Chief Financial Officer, Executive Vice President
Camille Farhat
President of American Medical Systems
Brian Lortie
President, U.S. Branded Pharmaceuticals
Susan Hall Ph.D.
Executive Vice President, Chief Scientific Officer, and Global Head of Research & Development and Quality
Matthew Joseph Maletta
Executive Vice President, Chief Legal Officer
Donald W. Degolyer
Chief Operating Officer, Pharmaceuticals
Craig Paterson M.D.
Chief Medical Officer
Douglas S. Ingram Esq.


Minerva House, Simmonscourt Road
DUBLIN, 00000
+353-1-2682000 (Phone)

Website links

Endo International plc is a global specialty healthcare company focused on branded and generic pharmaceuticals and devices. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, BELBUCA, Fortesta Gel, Testim, Aveed, Supprelin LA, and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American, South African and world markets. The Company sells generic products primarily in the United States across multiple therapeutic categories.

Related companies

* Delayed by up to 20 minutes -  Disclaimer